The Clinical Trial of Electro-thumbtack Needle on Live Birth Rate in Patients With Ovarian Reserve Dysfunction (DOR)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorHuazhong University of Science and Technology

About this trial

This study will include 246 patients with ovarian reserve dysfunction (DOR), who will be randomly divided into a treatment group and a control group, with 123 patients in each group. The treatment group will receive electro-thumbtack needle treatment, while the control group will receive placebo electro-thumbtack needle treatment. Both groups will receive a treatment course of 3 menstrual cycles. This study evaluates the effect of electrocautery on the live birth rate of patients with DOR.

Eligibility criteria

Qualifiers

The age range is 18-40 years old;

Meets the diagnostic criteria for DOR as follows: ① AMH<1.1 ng/ml; ② 10 U/L < FSH < 25U/L or FSH/LH > 3.6; ③ The total number of follicles (AFC) in both basal sinuses is less than 7. If any two of the above criteria (①②③) are met, it can be diagnosed as DOR.

At least one side of the patient's fallopian tube is unobstructed;

The semen routine examination of the patient's spouse is normal;

Disqualifiers

Chromosomal or genetic abnormalities in either the female or male partner;

Women with blocked fallopian tubes on both sides;

Have a history of ovarian surgery, such as ovarian teratoma or ovarian chocolate cyst surgery;

The female party suffers from uncorrected endocrine disorders such as simple hyperthyroidism or hypothyroidism, hyperprolactinemia, and pancreatic islet dysfunction;

Trial design

Treatments tested in this trial

  • electro-thumbtack needle
  • placebo electro-thumbtack needle

Treatment groups

368 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators